The treatment of Cataracts & High Triglycerides with vitamins

Cataracts and High Triglycerides: Mitamins custom make quality formulas for the treatment of Cataracts & High Triglycerides with vitamins. A Cataracts & High Triglycerides formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and High Triglycerides

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Riboflavin
    75
    mg
    4412%
    Selenium
    200
    mcg
    286%
    Chromium
    50
    mcg
    42%
    Alpha Lipoic Acid
    50
    mg
    *
    Omega - 3 Fatty Acids
    50
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Garlic Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    Guggul Extract
    25
    mg
    *
    Shiitake Extract
    50
    mg
    *
    Cayenne Extract
    50
    mg
    *
    Olive Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cataracts and High Triglycerides
Serving Size:4-5

Cataracts and High Triglycerides Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
Palatin Technologies, Inc. (Amex: PTN) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that they have delayed plans for the initiation of Phase 3 clinical trials with bremelanotide, a first in class melanocortin agonist drug candidate, for the treatment of male erectile dysfunction (ED). The decision follows responses from representatives of the U.S.
Fetal Cell "Transplant" Could Be A Hidden Link Between Childbirth And Reduced Risk Of Breast Cancer
Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer. In Seattle, Washington, researchers at the University of Washington and Fred Hutchinson Cancer Research Center believe they have identified a source of this protective effect: fetal cells "transplanted" to the mother before birth.
This information concerning the support of Cataracts and High Triglycerides treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments